Water displacement leg volumetry in clinical studies--a discussion of error sources

Eberhard Rabe, Markus Stücker, Bertram Ottillinger, Eberhard Rabe, Markus Stücker, Bertram Ottillinger

Abstract

Background: Water displacement leg volumetry is a highly reproducible method, allowing the confirmation of efficacy of vasoactive substances. Nevertheless errors of its execution and the selection of unsuitable patients are likely to negatively affect the outcome of clinical studies in chronic venous insufficiency (CVI).

Discussion: Placebo controlled double-blind drug studies in CVI were searched (Cochrane Review 2005, MedLine Search until December 2007) and assessed with regard to efficacy (volume reduction of the leg), patient characteristics, and potential methodological error sources. Almost every second study reported only small drug effects (<or= 30 mL volume reduction). As the most relevant error source the conduct of volumetry was identified. Because the practical use of available equipment varies, volume differences of more than 300 mL--which is a multifold of a potential treatment effect--have been reported between consecutive measurements. Other potential error sources were insufficient patient guidance or difficulties with the transition from the Widmer CVI classification to the CEAP (Clinical Etiological Anatomical Pathophysiological) grading.

Summary: Patients should be properly diagnosed with CVI and selected for stable oedema and further clinical symptoms relevant for the specific study. Centres require a thorough training on the use of the volumeter and on patient guidance. Volumetry should be performed under constant conditions. The reproducibility of short term repeat measurements has to be ensured.

References

    1. Henschke N, Boland RA, Adams RD. Responsiveness of two methods for measuring foot and ankle volume. Foot Ankle Int. 2006;27(10):826–832.
    1. Perrin M, Guex JJ. Edema and leg volume: methods of assessment. Angiology. 2000;51(1):9–12. doi: 10.1177/000331970005100103.
    1. Vayssairat M, Maurel A, Gouny P, Baudot N, Gaitz JP, Nussaume O. La volumétrie: Une méthode précise de quantification en phlébologie. J Mal Vasc. 1994;19(2):108–110.
    1. Thulesius O, Norgren L, Gjöres JE. Foot-volumetry, a new method for objective assessment of edema and venous function. VASA. 1973;2(4):325–329.
    1. Diebschlag W, Nocker W, Lehmacher W, Rehn D. A clinical comparison of two doses of 0-(β-Hydroxyethyl)-rutosides (oxerutins) in patients with chronic venous insufficiency. J Pharm Med. 1994;4:7–14.
    1. Diehm C, Trampisch HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet. 1996;347:292–294. doi: 10.1016/S0140-6736(96)90467-5.
    1. Rudofsky G, Diehm C, Gruß J, Hartmann M, Schultz-Ehrenburg HK, Bisler H. Chronisch venöse Insuffizienz. Behandlung mit Ruscus-Extrakt und Trimethylhesperidinchalkon. Münch Med Wschr. 1990;132(13):205–210.
    1. Diehm C, Schmidt C. In: BMC Cardiovascular Disorders. Ottillinger B, Greeske K, editor. Vol. 1. 2001. Venostasin® retard gegen Plazebo und Kompression bei Patienten mit CVI II/IIIA. Final Study Report 2000. Rational therapy of chronic venous insufficiency - chances and limits of the therapeutic use of horse-chestnut seeds extract; p. 5.
    1. Unkauf M, Rehn D, Klinger J, de la Motte S, Grossmann K. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings. Arzneimittelforschung. 1996;46(5):478–482.
    1. Vanscheidt W, Jost V, Wolna P, Lücker PW, Müller A, Theurer Ch, Patz B, Grützner KI. Efficacy and Safety of a Butcher's Broom Preparation (Ruscus aculeatus L. Extract) Compared to Placebo in Patients Suffering from Chronic Venous Insufficiency. Arzneim-Forsch/Drug Res. 2002;52(4):243–250.
    1. Martinez MJ, Bonfill X, Moreno RM, Vargas E, Capellà D. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews. 2005;3:CD003229.
    1. Burnand KG, Powell S, Bishop C, Stacey M, Pulvertaft T. Effect of Paroven on skin oxygenation in patients with varicose veins. Phlebologie. 1989;4(1):15–22.
    1. Cesarone MR, Belcaro G, Rulo A, Griffin M, Ricci A, Ippolito E, De Sanctis MT, Incandela L, Bavera P, Cacchio M, Bucci M. Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry. Angiology. 2001;52(Suppl 2):S45–S48.
    1. Danielsson G, Jungbeck C, Peterson K, Norgren L. A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease. Eur J Vasc Endovasc Surg. 2002;23(1):73–76. doi: 10.1053/ejvs.2001.1531.
    1. Marshall M, Loew D, Schwahn-Schreiber C. Hydroxyethylrutoside zur Behandlung der chronischen Veneninsuffizienz Grad I und II. Phlebologie. 2005;34:157–164.
    1. Marshall M. Medikamentöse Therapie von chronischen Venenleiden. TW Dermatologie. 1993;23:244–248.
    1. Vanscheidt W, Heidrich H, Jünger M, Rabe E. Guidelines for testing drugs for chronic venous insufficiency. VASA. 2000;29:274–278. doi: 10.1024/0301-1526.29.4.274.
    1. Brijker F, Heijdra YF, Elshout FJ Van Den, Bosch FH, Folgering HT. Volumetric measurements of peripheral oedema in clinical conditions. Clin Physiol. 2000;20(1):56–61. doi: 10.1046/j.1365-2281.2000.00224.x.
    1. Kiesewetter H, Koscielny J, Kalus U, Vix JM, Peil H, Petrini O, van Toor BS, de Mey C. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial. Arzneimittelforschung. 2000;50(2):109–117.
    1. Danielsson G, Norgren L, Jungbeck C, Peterson K. Global venous function correlates better than duplex derived reflux to clinical class in the evaluation of chronic venous disease. Int Angiol. 2003;22(2):177–181.
    1. Kaulesar Sukul DM, den Hoed PT, Johannes EJ, van Dolder R, Benda E. Direct and indirect methods for the quantification of leg volume: comparison between water displacement volumetry, the disk model method and the frustum sign model method, using the correlation coefficient and the limits of agreement. J Biomed Eng. 1993;15(6):477–480. doi: 10.1016/0141-5425(93)90062-4.
    1. King TI. The effect of water temperature on hand volume during volumetric measurement using the water displacement method. J Hand Ther. 1993;6(3):202–204.
    1. Krijnen RM, de Boer EM, Adèr HJ, Bruynzeel DP. Venous insufficiency in male workers with a standing profession. Part 2: diurnal volume changes of the lower legs. Dermatology. 1997;194(2):121–126. doi: 10.1159/000246078.
    1. Man IOW, Lepar GS, Morrissey MC, Cywinski JK. Effect of neuromuscular electrical stimulation on foot/ankle volume during standing. Med Sci Sports Exerc. 2003;35(4):630–634. doi: 10.1249/01.MSS.0000058432.29149.08.
    1. Vayssairat M, Ziani E, Houot B. Efficacité versus placebo de la contention classe 1 dans l'insuffisance veineuse chronique des membres inférieurs. J Mal Vasc. 2000;25(4):256–262.
    1. Rabe E, ed. Grundlagen der Phlebologie. 3. Vol. 62. Cologne: Viavital-Verlag; 2003.
    1. Pannier F, Rabe E. Volumenänderungen der unteren Extremitäten in Orthostase. Phlebologie. 2004;33:81–88.
    1. Ihme N, Kiesewetter H, Jung F, Hoffmann KH, Birk A, Müller A, Grützner KI. Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single-centre, randomised, double-blind, placebo-controlled clinical trial. Eur J Clin Pharmacol. 1996;50(6):443–447. doi: 10.1007/s002280050138.
    1. Curtis SP, Ng J, Yu Q, Shingo S, Bergman G, McCormick CL, Reicin AS. Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials. Clin Ther. 2004;26(1):70–83. doi: 10.1016/S0149-2918(04)90007-0.
    1. Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, Brune K. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther. 2002;72(1):50–61. doi: 10.1067/mcp.2002.126182.
    1. Gallenkemper G, Bulling BJ, Gerlach H, Jünger M, Kahle B, Klüken N, Lehnert W, Rabe E, Schwahn-Schreiber Chr. Leitlinien zur Diagnostik und Therapie des chronischen venösen Insuffizienz (CVI) Phlebol. 1998;27:32–35.
    1. Vanscheidt W, Rabe E, Naser-Hijazi B, Ramelet AA, Partsch H, Diehm C, Schultz-Ehrenburg U, Spengel F, Wirsching M, Götz V, Schnitker J, Henneicke-von Zepelin HH. The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study. VASA. 2002;31(3):185–190. doi: 10.1024/0301-1526.31.3.185.
    1. Casley-Smith JR. A double-blind trial of calcium dobesilate in chronic venous insufficiency. Angiology. 1988;39(10):853–857. doi: 10.1177/000331978803901001.

Source: PubMed

3
Předplatit